The grant follows the previously disclosed notice of allowance in Europe regarding protection of the Company's tested and proven ballistics technology and related intellectual property.
Read More
This press release replaces the release issued today at 9:15am EDT.
Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy.
Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine Learning
Read More